Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license
Developmental and Epileptic Encephalopathy, 32, as genome-wide studies have reported it: 29 positions from 1 study. Assembled by code from the GWAS Catalog's records and kept current as positions arrive; every figure is the studies' own.
Developmental and Epileptic Encephalopathy, 32 — filed in the GWAS Catalog as "Developmental and epileptic encephalopathy, 32" — is a condition this catalogue follows as its positions arrive. This page is assembled by MyGeneLog's own code from the catalogue's records and the studies' own listings: 29 positions from 1 study, and no sentence written by hand. It is rebuilt as new positions are reported, so what it says is what the records say today.
A study. It contributes 29 positions: rs1064794738 (KCNA2), rs1553181257 (KCNA2), rs1553181280 (KCNA2), rs1553181282 (KCNA2), rs1553181301 (KCNA2), rs1557731896 (KCNA2), rs1570752696 (KCNA2), rs1649470988 (KCNA2), and 21 more.
The catalogue maps the 29 positions to 1 gene: KCNA2. That mapping says where a position sits, in a gene or beside one — not what it does. For what each study measured, follow its citation above.
It is a record of what genome-wide studies have reported about Developmental and Epileptic Encephalopathy, 32, kept current by code. It is not a description of the condition, an estimate of how common it is, or guidance of any kind — a page that took those from association records would be inventing them. Each variant page linked here carries that study's own record for the position in fixed sentences, and ClinVar's record where one exists.
A genotype does not diagnose Developmental and Epileptic Encephalopathy, 32; a clinician does. No guideline uses the 29 variants on this page to predict it, screen for it or confirm it.
Its sources are association records, and association records carry no clinical guidance, so neither does this page. What a genome-wide study reports is a difference between groups of people, not a finding about any one person. Symptoms, tests and treatment are questions for a clinician.
Databases, guidelines and references
Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license
Developmental and Epileptic Encephalopathy, 32. MyGeneLog™. https://www.mygenelog.com/conditions/developmental-and-epileptic-encephalopathy-32
Developmental and Epileptic Encephalopathy, 32 is the condition the GWAS Catalog files under "Developmental and epileptic encephalopathy, 32". This page does not define it in its own words; it lists what genome-wide studies have reported: 29 positions from 1 study, with each study's sample and citation.
Genes play a part: 29 positions have been linked to it. But each is a common variant of small effect, and a link found across a population does not cause the condition in any one person.
The positions lie in or near 1 gene: KCNA2. A mapped gene is the catalogue's location for a position, not a mechanism.
No. They are population-level findings of small effect. Developmental and Epileptic Encephalopathy, 32 is diagnosed by a clinician, and no guideline uses a genotype to predict it.
Free to reuse, non-commercially. This page's text is original writing from freely-available research, licensed CC BY-NC 4.0 — share and adapt it with attribution to MyGeneLog™; commercial use is licensed. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.